Baheal Pharma Group is a health industry group driven by technological innovation, with core businesses including medical innovation incubation, manufacturing and commercialization. Based on the deep insights into medical scenarios and advanced incubation mechanisms, Baheal has established a Research and Development Platform that collaborates with National Research Institutions to discover original innovations based on basic biological R&D and innovative achievements investment incubation with First-in-Class potential. Baheal Pharma Group’s listed enterprise, Baheal Medical, as an industrialization platform with innovative brand-building capabilities, aims to accelerate the introduction of medical innovations into clinical applications constantly. Currently, we have formed a diversified products matrix in the fields of bone health, anti-organ fibrosis and brain metastases and have successfully incubated multiple category-leading brands.